Quantcast
Home > Quotes > KOOL
KOOL

Cesca Therapeutics Inc. Common Stock (KOOL) Quote & Summary Data

$0.2622
*  
0.0002
0.08%
Get KOOL Alerts
*Delayed - data as of May 22, 2019 9:51 ET  -  Find a broker to begin trading KOOL now
Exchange:NASDAQ
Industry: Capital Goods
Community Rating:
View:    KOOL Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 0.2621 / $ 0.265
1 Year Target
1
Today's High / Low
$ 0.265 / $ 0.2622
Share Volume
4,255
50 Day Avg. Daily Volume
193,385
Previous Close
$ 0.262
52 Week High / Low
$ 0.58 / $ 0.21
Market Cap
6,200,806
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.78

Intraday Chart

Shares Traded

Share Volume:
4,255
50 Day Avg. Daily Volume:
193,385

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -2.08

Trading Range

The current last sale of $0.2622 is 24.86% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.265 $ 0.58
 Low: $ 0.2622 $ 0.21

Company Description (as filed with the SEC)

Cesca Therapeutics Inc. ("Cesca Therapeutics," "Cesca," the "Company," "we," "our," "us"), a Delaware corporation founded in 1986, develops, commercializes and markets a range of automated technologies for cell-based therapies. Since the 1990's, Cesca has been a pioneer in, and one of the leading developers and suppliers of automation technologies for the isolation, purification and storage of stem cells for the cord blood banking industry. In July 2017, a Cesca subsidiary, ThermoGenesis Corp. (ThermoGenesis), completed the strategic acquisition of the business and substantially all of the assets of SynGen Inc., a research and development company for automated cellular processing, in exchange for a 20% interest in ThermoGenesis.  ... More ...  



Risk Grade

Where does KOOL fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 0.265
Open Date:
May 22, 2019
Close Price:
N/A
Close Date:
N/A


Consensus Recommendation

Analyst Info